Pyrosequencing analysis of fecal microbiota composition in mice fed with prebiotics.
Items | Treatments | |||||
---|---|---|---|---|---|---|
C | N | P | T1 | T2 | T3 | |
mean % (SD) | mean % (SD) | mean % (SD) | mean % (SD) | mean % (SD) | mean % (SD) | |
81.38 (3.34) | 87.82 (1.29) |
79.52 (2.22) |
63.59 (5.68) |
76.12 (7.89) |
63.58 (6.21) |
|
65.67 (8.08) | 83.05 (3.59) |
78.24 (0.83) |
55.26 (7.32) |
74.33 (7.48) | 56.45 (3.06) |
|
42.76 (7.83) | 70.47 (2.96) |
69.38 (2.08) | 39.89 (3.06) |
47.37 (4.82) |
30.39 (6.62) |
|
7.89 (1.37) | 7.53 (0.54) | 7.98 (1.38) | 8.91 (2.65) | 14.14 (1.74) |
5.45 (1.18) |
|
21.78 (4.98) | 9.12 (0.59) |
8.93 (0.77) |
18.46 (3.91) |
20.54 (3.47) |
21.77 (3.72) |
|
1.91 (0.67) | 0.00 (0.00) |
0.00 (0.00) |
2.98 (0.66) |
3.02 (0.72) |
2.57 (1.30) |
|
14.82 (8.22) | 4.66 (4.80) | 1.11 (1.73) |
4.26 (3.84) | 5.02 (4.11) | 2.94 (1.47) | |
20.63 (7.96) | 2.00 (1.52) |
0.32 (0.26) |
5.77 (3.35) |
4.32 (1.43) |
2.78 (1.42) |
|
19.86 (7.69) | 1.97 (1.49) |
0.31 (0.26) |
5.53 (3.17) |
4.11 (1.37) |
2.66 (1.32) |
|
16.81 (3.77) | 9.22 (1.79) |
16.41 (2.42) |
33.47 (5.26) |
21.56 (7.96) |
31.89 (9.12) |
|
16.80 (3.78) | 9.22 (1.79) |
16.40 (2.42) |
33.47 (5.27) |
16.22 (4.89) |
31.88 (9.11) |
|
0.71 (0.09) | 0.52 (0.20) | 0.85 (0.11) |
26.02 (6.74) |
2.52 (2.00) | 26.09 (8.54) |
|
0.67 (0.08) | 0.15 (0.01) |
0.40 (0.16) |
24.47 (6.26) |
2.28 (1.76) | 24.41 (8.23) |
|
8.59 (1.89) | 4.82 (1.59) |
6.97 (0.83) | 7.08 (1.56) | 7.64 (0.59) |
4.51 (1.59) |
C: Untreated control, N: AD control (DNCB-induced), P: Zyrtec-positive control (DNCB-induced + Zyrtec), T1: scGOS/lcFOS (DNCB-induced + scGOS/lcFOS), T2: Inulin (DNCB-induced + Inulin), T3: β-glucan (DNCB-induced + β-glucan); *